Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04342819

The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study. — EFFECT  

Platelet Dysfunction Due to Drugs Clinical Trial

Official title:
The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study.

Clinical Trial Summary

The mechanistic effects of empagliflozin on platelet function profiles have not yet been ascertained.

Clinical Trial Description

Sodium GLucose Transport 2 inhibitors (SGLT2I), including empagliflozin, reduce the likelihood of hospitalization for heart failure and death in persons with type 2 diabetes, of which the mechanism has not been fully elucidated. The mechanistic effects of empagliflozin on platelet function profiles have not yet been ascertained. It remains unclear if this reduction in cardiovascular death is mediated by decreased platelet reactivity. ;

Study Design

Related Conditions & MeSH terms

  • Platelet Dysfunction Due to Drugs
Clinical Trial Details
NCT number NCT04342819
Study type Interventional
Source The University of The West Indies
Contact
Status Completed
Phase Phase 2/Phase 3
Start date January 1, 2020
Completion date December 31, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT04206176 - The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease Phase 1/Phase 2
Completed NCT02979158 - Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass N/A
Withdrawn NCT03338660 - Platelet Function With Various Storage Techniques Phase 2
Completed NCT03603249 - Trimetazidine as an Adjunct to Enhance Clopidogrel Response. Phase 2
Completed NCT03111420 - Study of AggreGuide A-100 (ADP) Assay N/A
Recruiting NCT03005704 - Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets N/A
Recruiting NCT06228820 - Aspirin Resistance in Trinidad. Phase 2
Completed NCT03121898 - PLATelet Function Operating Room Monitoring
Active, not recruiting NCT03787927 - Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets Phase 1/Phase 2
Withdrawn NCT02974777 - The IDEAL-PCI Extended Registry Phase 4